These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 7473132

  • 1. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    Smith RL, Barrett RJ, Sanders-Bush E.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
    [Abstract] [Full Text] [Related]

  • 2. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
    Smith RL, Gresch PJ, Barrett RJ, Sanders-Bush E.
    Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
    [Abstract] [Full Text] [Related]

  • 3. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S, Asgari K, Rickard JF, Zhang Z, Fone KC, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [Abstract] [Full Text] [Related]

  • 4. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
    Asgari K, Body S, Bak VK, Zhang ZQ, Rickard JF, Glennon JC, Fone KC, Bradshaw CM, Szabadi E.
    Behav Pharmacol; 2006 Feb; 17(1):51-9. PubMed ID: 16377963
    [Abstract] [Full Text] [Related]

  • 5. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T, Walker EA, Woods JH.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the 5-HT2 receptor ligands dimethoxy-4-indophenyl-2-aminopropane and ketanserin in ethanol discriminations.
    Szeliga KT, Grant KA.
    Alcohol Clin Exp Res; 1998 May; 22(3):646-51. PubMed ID: 9622445
    [Abstract] [Full Text] [Related]

  • 7. Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212.
    Hemrick-Luecke SK, Fuller RW.
    Eur J Pharmacol; 1996 Sep 12; 311(2-3):207-11. PubMed ID: 8891601
    [Abstract] [Full Text] [Related]

  • 8. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA, Ageel AM, Ginawi OT.
    Neuropharmacology; 1993 Dec 12; 32(12):1427-32. PubMed ID: 8152532
    [Abstract] [Full Text] [Related]

  • 9. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on the discrimination of durations: evidence for the involvement of 5-HT2A but not 5-HT3 receptors.
    Asgari K, Body S, Rickard JF, Zhang Z, Fone KC, Bradshaw CM, Szabadi E.
    Behav Pharmacol; 2005 Feb 12; 16(1):43-51. PubMed ID: 15706137
    [Abstract] [Full Text] [Related]

  • 10. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.
    McMahon LR, Cunningham KA.
    J Pharmacol Exp Ther; 2001 Apr 12; 297(1):357-63. PubMed ID: 11259563
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA, Young R, Rosecrans JA.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):189-96. PubMed ID: 6617740
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
    Callahan PM, Cunningham KA.
    J Pharmacol Exp Ther; 1995 Sep 22; 274(3):1414-24. PubMed ID: 7562516
    [Abstract] [Full Text] [Related]

  • 13. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
    Li JX, Unzeitig A, Javors MA, Rice KC, Koek W, France CP.
    J Pharmacol Exp Ther; 2009 Nov 22; 331(2):671-9. PubMed ID: 19687292
    [Abstract] [Full Text] [Related]

  • 14. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr 22; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 15. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.
    McCreary AC, Filip M, Cunningham KA.
    Behav Neurosci; 2003 Apr 22; 117(2):212-21. PubMed ID: 12708517
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
    Hemrick-Luecke SK, Evans DC.
    Neuropharmacology; 2002 Feb 22; 42(2):162-9. PubMed ID: 11804612
    [Abstract] [Full Text] [Related]

  • 17. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    Friedman RL, Barrett RJ, Sanders-Bush E.
    J Pharmacol Exp Ther; 1984 Mar 22; 228(3):628-35. PubMed ID: 6707913
    [Abstract] [Full Text] [Related]

  • 18. In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics.
    Sánchez C, Arnt J.
    Behav Pharmacol; 2000 Jun 22; 11(3-4):291-8. PubMed ID: 11103883
    [Abstract] [Full Text] [Related]

  • 19. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
    Hewson G, Leighton GE, Hill RG, Hughes J.
    Br J Pharmacol; 1988 Oct 22; 95(2):598-604. PubMed ID: 2906561
    [Abstract] [Full Text] [Related]

  • 20. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS, Eison MS, Yocca FD, Gianutsos G.
    Life Sci; 1989 Oct 22; 44(19):1419-27. PubMed ID: 2785627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.